That's for every patient. So where is a trial being run with DCVax without concurrent chemo that would allow them to show that chemo is not part of the process (obviously assuming you think DCVax actually does something)?
Just goes to show how complicated the insurance decisions are in the US based on likelihood of any given scenario. Every situation is different as explained in this case where the patient had no previous chronic need for expensive drugs like many do prior to her cancer diagnosis. These folks were blessed to hit the correct plans for their situation. Many are not so blessed and nothing was stated about how plan D for drug coverage was handled and the added cost of that when considering supplement coverage. Risk management for any given individual is very difficult with so many unknown factors. This is why reducing actual cost related risk through negative and positive reinforcements over a lifetime of health related individual decisions should be a top priority for all community health related coverages. Best wishes.